TRC160334
TRC160334 is a hypoxia-inducible factor (HIF) hydroxylase inhibitor. TRC160334 can be used for the research of ischemia/reperfusion injury[1].
Product Specifications
CAS Number
1293289-69-6
UNSPSC
12352005
Target
HIF/HIF Prolyl-Hydroxylase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/trc160334.html
Concentration
10mM
Purity
98.22
Solubility
DMSO : 25 mg/mL (ultrasonic; warming; heat to 80°C)
Smiles
O=C(C1=C(O)N=C(SC2=C3CCCCC2)N3C1=O)NCC(O)=O
Molecular Formula
C14H15N3O5S
Molecular Weight
337.35
References & Citations
[1]Jamadarkhana P, et al. Treatment with a novel hypoxia-inducible factor hydroxylase inhibitor (TRC160334) ameliorates ischemic acute kidney injury. Am J Nephrol. 2012;36 (3) :208-218.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![CD35 Mouse Monoclonal Antibody [A4F3]](https://cdn.genprice.uk/products/992/68dd1c8b061270361ea8164b/imageurl/ha601022.webp)
TRC-H949155-25MG 25 mg
14Beta-Hydroxy-13-oxo-7-O-(triethylsilyl) Baccatin III 1,14-Carbonate
Sign In for Pricing
View Details 
